About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3774672
Allelic
Composition
Tg(KRT14-Snai1)1Efu/0
Genetic
Background
involves: CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype

Tg(KRT14-Snai1)1Efu/0 mice are small, have short tails and flaky skin, and exhibit epidermal hyperproliferation

cellular
• keratinocytes are more resistant to chemotoxic stress
• keratinocytes form more and larger colonies than wild-type cells
• treatment of isolated keratinocytes from newborns with 2,4-dimethoxybenzaldehyde (DMBA) results in enhanced proliferation and a survival advantage
• isolated keratinocytes treated with the chemotherapeutic drug doxorubicin show a survival advantage

growth/size/body
• progressively poor health

endocrine/exocrine glands
• sebaceous gland cells are hyperproliferative and lack terminal differentiation
• in adults, the Mts24+progenitor population that gives rise to the sebaceous gland cells is expanded
• clonogenic potential of Mts24+ progenitor cells is enhanced
• sebaceous gland cells start to accumulate and several glands per hair follicle are formed, with this disorganization becoming worse over time and leading to sebaceous gland hyperplasia and carcinoma
• 40% incidence of sebaceous gland carcinoma
• sebaceous gland carcinoma is often mixed with squamous cell carcinoma implying an early progenitor population that becomes transformed but still retains some differentiation characteristics

behavior/neurological
• reduction in food intake

neoplasm
• 40% incidence of sebaceous gland carcinoma
• sebaceous gland carcinoma is often mixed with squamous cell carcinoma implying an early progenitor population that becomes transformed but still retains some differentiation characteristics
• mice start to develop spontaneous skin tumors at 5 months of age, with a median latency of 282 days
• tumors include basal cell carcinoma, squamous cell carcinoma, sebaceous gland carcinoma, and mixed tumors (40%)
• 6.67% incidence of basal cell carcinoma
• 13.33% incidence of squamous cell carcinoma
• sebaceous gland carcinomas are highly metastatic, with draining lymph nodes of 59% of mice with sebaceous gland carcinomas containing carcinoma cells with sebaceous differentiation
• mice show lung metastasis displaying features of terminal skin differentiation in mice with squamous cell carcinoma

limbs/digits/tail

integument
• keratinocytes form more and larger colonies than wild-type cells
• treatment of isolated keratinocytes from newborns with 2,4-dimethoxybenzaldehyde (DMBA) results in enhanced proliferation and a survival advantage
• isolated keratinocytes treated with the chemotherapeutic drug doxorubicin show a survival advantage
• sebaceous gland cells are hyperproliferative and lack terminal differentiation
• in adults, the Mts24+progenitor population that gives rise to the sebaceous gland cells is expanded
• clonogenic potential of Mts24+ progenitor cells is enhanced
• sebaceous gland cells start to accumulate and several glands per hair follicle are formed, with this disorganization becoming worse over time and leading to sebaceous gland hyperplasia and carcinoma
• 40% incidence of sebaceous gland carcinoma
• sebaceous gland carcinoma is often mixed with squamous cell carcinoma implying an early progenitor population that becomes transformed but still retains some differentiation characteristics
• epidermis is hyperproliferative and exhibits differentiation defects
• with age, epidermal folds and undulations develop in the epithelium
• adults exhibit alteration of the basement membrane that separates the epidermis from the dermis
• mice start to develop spontaneous skin tumors at 5 months of age, with a median latency of 282 days
• tumors include basal cell carcinoma, squamous cell carcinoma, sebaceous gland carcinoma, and mixed tumors (40%)
• 6.67% incidence of basal cell carcinoma
• 13.33% incidence of squamous cell carcinoma

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
skin cancer DOID:4159 J:229072


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory